Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Funds research to develop, validate, and translate digital biomarkers (e.g., wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
Imaging Research in Alzheimer’s and Other Neurodegenerative Diseases Grant supports investigators’ pilot imaging research to improve diagnosis, prognosis, and understanding of Alzheimer’s and related diseases.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development supports FTD researchers through a partnership with The Association for Frontotemporal Degeneration to advance biomarkers for diagnosis and treatment.